"Dedicated highly specialised physician amongst the team of stalwarts in the Department of Hepatology. The Department serves patients with all types of liver diseases, alcohol related liver disease, fatty liver, hepatitis B and hepatitis C, gall stone disease, CBD stones, pancreatic diseases, etc. Department also deals with medical management of liver transplant patients. Department also specialises in the endoscopic procedures (upper and lower), ERCP, EUS, Fibroscan and specialized liver tests. Dedicated Research in hepatobiliary sciences and liver transplantation is being conducted as per ethical guidelines and ensuring no harm to humans or animals."

During the past decade, Dept. of Hepatology, PGIMER conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dept. of Hepatology, PGIMER" #1 collaborator was "Postgraduate Institute of Medical Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dept. of Hepatology, PGIMER" are "Alcoholic Hepatitis" (1 trials), "Ascites Hepatic" (1 trials), "Cirrhosis" (1 trials) and "Hepatic Encephalopathy" (1 trials). Many other conditions were trialed in "Dept. of Hepatology, PGIMER" in a lesser frequency.

Most popular intervention types in "Dept. of Hepatology, PGIMER" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin (10Mg Tab) along with standard medical therapy" (1 trials), "G-CSF" (1 trials), "Placebo" (1 trials), "Placebo of dapaglifozin along with standard medical therapy" (1 trials) and "VSL#3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Hepatology, PGIMER" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dept. of Hepatology, PGIMER". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dept. of Hepatology, PGIMER, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Hepatology, PGIMER, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".